Functional screening identifies miRNAs inducing cardiac regeneration

Nature

Volumn 492, Issue 7429, 2012, Pages 376-381

  Eulalio, Ana ^a,d   Mano, Miguel ^a   Ferro, Matteo Dal ^a,b,c   Zentilin, Lorena ^a   Sinagra, Gianfranco ^b,c   Zacchigna, Serena ^a   Giacca, Mauro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA B KINASE; HISTONE H3; MICRORNA; MICRORNA 199A; MICRORNA 590; UNCLASSIFIED DRUG;

CARDIOLOGY; CARDIOVASCULAR DISEASE; EMBRYONIC DEVELOPMENT; MITOCHONDRIAL DNA; PATHOLOGY; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINESIS; DNA SYNTHESIS; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HIGH THROUGHPUT SCREENING; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; RNA SEQUENCE; TISSUE REGENERATION;

ANIMALS; CELL PROLIFERATION; CYTOKINESIS; DNA; DOWN-REGULATION; GENE LIBRARY; GENETIC THERAPY; HEART; HUMANS; MICE; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; REGENERATION;

ANIMALIA; MAMMALIA; MUS; RATTUS;

EID: 84871442001     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11739     Document Type: Article

References (50)

1. Ahuja, P., Sdek, P. & MacLellan, W. R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87, 521-544 (2007).
2. van Amerongen, M. J. & Engel, F. B. Features ofCMproliferation and its potential for cardiac regeneration. J. Cell. Mol. Med. 12, 2233-2244 (2008).
3. Bicknell, K. A., Coxon, C. H. & Brooks, G. Can the CM cell cycle be reprogrammed? J. Mol. Cell. Cardiol. 42, 706-721 (2007).
4. Bergmann, O. et al. Evidence forCMrenewal inhumans. Science324, 98-102(2009).
5. Kajstura, J. et al. Cardiomyogenesis in the adult human heart. Circ. Res. 107, 305-315 (2010).
6. Beltrami, A. P. et al. Evidence that human cardiacmyocytes divide aftermyocardial infarction. N. Engl. J. Med. 344, 1750-1757 (2001).
7. Robledo, M. Myocardial regenerationinyoungrats. Am. J. Pathol. 32, 1215-1239(1956).
8. Nag, A. C., Carey, T. R. & Cheng, M. DNA synthesis in rat heart cells after injury and the regeneration of myocardia. Tissue Cell 15, 597-613 (1983).
9. Kajstura, J. et al. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowinginduced cardiomyopathy in rats. Circ. Res. 74, 383-400 (1994).
10. Reiss, K., Kajstura, J., Capasso, J. M., Marino, T. A. & Anversa, P. Impairment of myocyte contractility following coronary artery narrowing is associated with activation of the myocyte IGF1 autocrine system, enhanced expression of late growth related genes, DNAsynthesis, andmyocyte nuclear mitotic division in rats. Exp. Cell Res. 207, 348-360 (1993).
11. Bartel, D. P. MiRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
12. Pasquinelli, A. E. MiRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nature Rev. Genet. 13, 271-282 (2012).
13. Chen, J. F. et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl Acad. Sci. USA 105, 2111-2116 (2008).
14. Rao, P. K. et al. Loss of cardiac miRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res. 105, 585-594 (2009).
15. Ikeda, S. et al. Altered miRNA expression in human heart disease. Physiol. Genomics 31, 367-373 (2007).
16. Matkovich, S. J. et al. Reciprocal regulation of myocardial miRNAs and messenger RNA in human cardiomyopathy and reversal of the miRNA signature by biomechanical support. Circulation 119, 1263-1271 (2009).
17. Thum, T. et al. MiRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116, 258-267 (2007).
18. van Rooij, E. et al. A signature pattern of stress-responsive miRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl Acad. Sci. USA 103, 18255-18260 (2006).
19. Zhao, Y., Samal, E. & Srivastava, D. Serumresponsefactor regulatesamuscle-specific miRNA that targets Hand2 during cardiogenesis. Nature 436, 214-220 (2005).
20. Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317 (2007).
21. Liu, N. et al. miRNA-133a regulates CM proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22, 3242-3254 (2008).
22. Porrello, E. R. et al. MiR-15 family regulates postnatal mitotic arrest of CMs. Circ. Res. 109, 670-679 (2011).
23. Salic, A. & Mitchison, T. J. A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc. Natl Acad. Sci. USA 105, 2415-2420 (2008).
24. Soonpaa, M. H., Kim, K. K., Pajak, L., Franklin, M. & Field, L. J. CMDNA synthesis and binucleationduring murine development. Am. J. Physiol. 271, H2183-H2189(1996).
25. Li, F., Wang, X., Capasso, J. M. & Gerdes, A. M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 28, 1737-1746 (1996).
26. Kubin, T. et al. Oncostatin M is a major mediator of CM dedifferentiation and remodeling. Cell Stem Cell 9, 420-432 (2011).
27. Fredj, S., Bescond, J., Louault, C. & Potreau, D. Interactions between cardiac cells enhanceCMhypertrophy and increase fibroblast proliferation. J. Cell. Physiol. 202, 891-899 (2005).
28. Zhang, Y. et al. Dedifferentiation and proliferation ofmammalianCMs. PLoSONE 5, e12559 (2010).
29. Bird, S. D. et al. ThehumanadultCMphenotype. Cardiovasc. Res. 58, 423-434(2003).
30. Pouliquin, P. & Dulhunty, A. F. Homer and the ryanodine receptor. Eur. Biophys. J. 39, 91-102 (2009).
31. Trivedi, C. M. et al. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev. Cell 19, 450-459 (2010).
32. Inagaki, K. et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14, 45-53 (2006).
33. Katare, R. et al. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ. Res. 108, 1238-1251 (2011).
34. Secchiero, P. et al. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. Circulation 114, 1522-1530 (2006).
35. Ahuja, P., Perriard, E., Perriard, J. C. & Ehler, E. Sequentialmyofibrillar breakdown accompaniesmitoticdivisionofmammalianCMs. J. Cell Sci. 117, 3295-3306(2004).
36. Zentilin, L. et al. CM VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J. 24, 1467-1478 (2010).
37. Collesi, C., Zentilin, L., Sinagra, G. & Giacca, M. Notch1 signaling stimulates proliferation of immature CMs. J. Cell Biol. 183, 117-128 (2008).
38. Jopling, C. et al. Zebrafish heart regeneration occurs by CM dedifferentiation and proliferation. Nature 464, 606-609 (2010).
39. Kikuchi, K. et al. Primary contribution to zebrafish heart regeneration by gata41 CMs. Nature 464, 601-605 (2010).
40. Poss, K. D., Wilson, L. G. & Keating, M. T. Heart regeneration in zebrafish. Science 298, 2188-2190 (2002).
41. Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080 (2011).
42. Dorn, G. W. II. Apoptotic and non-apoptotic programmed CM death in ventricular remodelling. Cardiovasc. Res. 81, 465-473 (2009).
43. Nishida, K. & Otsu, K. Celldeathinheart failure. Circ. J. 72(Suppl. A)A17-A21(2008).
44. Bolli, R. et al. Cardiac stemcells inpatientswithischaemic cardiomyopathy(SCIPIO): initial results of a randomised phase 1 trial. Lancet 378, 1847-1857 (2011).
45. Makkar, R. R. et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379, 895-904 (2012).
46. Xiao, L. et al. MEK1/2-ERK1/2 mediates a1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 33, 779-787 (2001).
47. Arsic, N. et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol. Ther. 7, 450-459 (2003).
48. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT Method. Methods 25, 402-408 (2001).
49. Sturn, A., Quackenbush, J. & Trajanoski, Z. Genesis: cluster analysis of microarray data. Bioinformatics 18, 207-208 (2002).
50. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 5, 621-628 (2008).